National Health Investors (NHI) Receivables - Accured (2023 - 2025)
Historic Revenue - Other for National Health Investors (NHI) over the last 16 years, with Q3 2025 value amounting to $27.2 million.
- National Health Investors' Revenue - Other rose 4131.38% to $27.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.8 million, marking a year-over-year increase of 1552.09%. This contributed to the annual value of $76.2 million for FY2024, which is 3763861.39% up from last year.
- Latest data reveals that National Health Investors reported Receivables - Accured of $158.4 million as of Q3 2025, which was up 99243.45% from $169.4 million recorded in Q2 2025.
- National Health Investors' 5-year Receivables - Accured high stood at $175.8 million for Q4 2024, and its period low was $14.5 million during Q3 2024.
- Moreover, its 3-year median value for Receivables - Accured was $158.4 million (2025), whereas its average is $145.9 million.
- Its Revenue - Other has fluctuated over the past 5 years, first soared by 12164285.71% in 2021, then plummeted by 3544.16% in 2022.
- Quarter analysis of 5 years shows National Health Investors' Revenue - Other stood at $25.6 million in 2021, then crashed by 35.44% to $16.5 million in 2022, then grew by 11.14% to $18.3 million in 2023, then rose by 6.15% to $19.5 million in 2024, then surged by 39.54% to $27.2 million in 2025.
- Its Revenue - Other stands at $27.2 million for Q3 2025, versus $20.2 million for Q2 2025 and $19.9 million for Q1 2025.